Abeona Therapeutics
ABEO
#7792
Rank
NZ$0.43 B
Marketcap
$10.08
Share price
1.24%
Change (1 day)
32.73%
Change (1 year)

Operating Margin for Abeona Therapeutics (ABEO)

Operating Margin as of December 2024 (TTM): -1,536.28%

According to Abeona Therapeutics 's latest financial reports and stock price the company's current Operating Margin is -1,536.28%. At the end of 2023 the company had an Operating Margin of -1,536.29%.

Operating Margin history for Abeona Therapeutics from 2001 to 2023

Operating Margin at the end of each year

Year Operating Margin Change
2023-1,536.29%-44.24%
2022-2,755.30%1.7%
2021-2,709.33%238.16%
2020-801.19%
2018-1,889.93%-42.08%
2017-3,262.96%32.66%
2016-2,459.73%76.18%
2015-1,396.15%-50.7%
2014-2,832.00%-1323.13%
2013231.54%-202.75%
2012-225.34%64.77%
2011-136.76%-90.51%
2010-1,440.75%-47.59%
2009-2,748.86%-73.97%
2008-10,560.48%-67.29%
2007-32,285.96%
2004-1,093.44%160.97%
2003-419.00%-44.76%
2002-758.50%-70.78%
2001-2,595.88%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
6.66%-100.43%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
3.14%-100.20%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.